MiDRMpol: A High-Throughput Multiplexed Amplicon Sequencing Workflow to Quantify HIV-1 Drug Resistance Mutations against Protease, Reverse Transcriptase, and Integrase Inhibitors
Aralaguppe, S.G.; Ambikan, A.T.; Ashokkumar, M.; Kumar, M.M.; Hanna, L.E.; Amogne, W.; Sönnerborg, A.; Neogi, U. MiDRMpol: A High-Throughput Multiplexed Amplicon Sequencing Workflow to Quantify HIV-1 Drug Resistance Mutations against Protease, Reverse Transcriptase, and Integrase Inhibitors. Viruses 2019, 11, 806. https://doi.org/10.3390/v11090806
Aralaguppe SG, Ambikan AT, Ashokkumar M, Kumar MM, Hanna LE, Amogne W, Sönnerborg A, Neogi U. MiDRMpol: A High-Throughput Multiplexed Amplicon Sequencing Workflow to Quantify HIV-1 Drug Resistance Mutations against Protease, Reverse Transcriptase, and Integrase Inhibitors. Viruses. 2019; 11(9):806. https://doi.org/10.3390/v11090806
Chicago/Turabian StyleAralaguppe, Shambhu G.; Ambikan, Anoop T.; Ashokkumar, Manickam; Kumar, Milner M.; Hanna, Luke E.; Amogne, Wondwossen; Sönnerborg, Anders; Neogi, Ujjwal. 2019. "MiDRMpol: A High-Throughput Multiplexed Amplicon Sequencing Workflow to Quantify HIV-1 Drug Resistance Mutations against Protease, Reverse Transcriptase, and Integrase Inhibitors" Viruses 11, no. 9: 806. https://doi.org/10.3390/v11090806